Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Yacht Buyer
  • Stocks
  • Education
  • Nyse
  • Finance
  • Banking
ncarol.com

NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
ncarol.com/10314398

Trending...
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
Nutraceuticals & Agriceuticals Technology Company
TEMECULA, Calif. - ncarol.com -- NATCO proudly announces that the United States Patent and Trademark Office (USPTO) has officially granted U.S. Patent No. 12,453,363 B2 for its latest invention, Persimonal®, a proprietary technology for preparing persimmon leaf extract.

This milestone patent underscores NATCO's commitment to advancing botanical science and delivering innovative, clinically relevant solutions in natural health and nutrition. Persimonal® represents a novel approach to harnessing the bioactive compounds of persimmon leaves, long valued in traditional medicine for their antioxidant, anti-inflammatory, and cardiovascular-supportive properties.

Key Highlights of Persimonal®
  • Patent Protection: U.S. Patent No. 12,453,363 B2 secures NATCO's proprietary process for preparing persimmon leaf extract.
  • Scientific Innovation: Persimonal® optimizes extraction to preserve and enhance the potency of polyphenols, flavonoids, and other beneficial compounds.
  • Health Potential: Persimmon leaf extract has been studied for supporting vascular health, lowering blood pressure and cholesterol, metabolic balance, and overall wellness.
  • Market Differentiation: Persimonal® positions NATCO at the forefront of botanical innovation, offering a unique, patent-backed ingredient for nutraceutical and functional food applications.

Executive Statement

More on ncarol.com
  • Interview: Why I Sponsored Carson Ware - The Full Story
  • March Is Skiing's Smartest Buying Window
  • Zeo Health Introduces KidZ Cleanse with Folinic Acid
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."

"The awarding of this U.S. patent validates NATCO's dedication to scientific excellence and innovation in natural product development," said [Abdul Alkayali], [Executive Vice President] at NATCO. "Persimonal® is more than an extraction method—it's a platform for unlocking the full potential of persimmon leaves to support human health."

About NATCO

NATCO is a leader in natural product innovation, specializing in proprietary technologies that transform traditional botanicals into clinically relevant, market-ready solutions. With a focus on science, sustainability, and consumer wellness, NATCO continues to pioneer advancements that set new standards in the nutraceutical industry.

www.natcohealthyliving.com

Contact
Abdul Alkayali
***@natcohealthyliving.com


Source: NATCO, Inc

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • Arcuri Group Announces Long‑Term Partnership with WakeMed Health & Hospitals to Deliver Situational Awareness and De‑escalation Training
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
  • Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy
  • FPTower Inc. nonprofit launches coastal safety raffle fundraiser
  • Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
  • STEM Agent Academy Mission 01: Reclaiming Children's Curiosity from the Digital Void
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
  • Talentica Announces Winners of Multi-Agent Hackathon 2026
  • Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
  • Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
  • 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
  • Husband and Wife Release Children's Book and Donate Proceeds to Non-Profit
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 113
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • Still Using Ice? FrostSkin Reinvents Hydration
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Super League (N A S D A Q: SLE) Advances AI-Driven Playable Media with AdArcade, Solsten, and Meta-Stadiums Partnerships, Plus Roblox Theatre Launch

Similar on ncarol.com

  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
  • Zeo Health Introduces KidZ Cleanse with Folinic Acid
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • CCHR: While Damaging Antipsychotics Win Approval, Proven Non-Drug Alternatives Remain Ignored
  • At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
  • Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute